FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288902561> ?p ?o ?g. }

• W4288902561 endingPage "10" @default.
• W4288902561 startingPage "1" @default.
• W4288902561 abstract "Nanodelivery is a modern technology involving improved delivery methods and drug formulations. The current development and initial applications of nanocarriers are pointing to new directions in the current development of nanomedicine. Researchers are increasingly applying nanodelivery to the delivery of therapeutic or diagnostic agents. This article discusses the preparation and application of nanocomplexes and nanoparticles, as well as their potential future value in clinical research. Through a review and analysis, it is hoped that this will serve as a guide for the future development of various nanodelivery technologies and help researchers learn more about these technologies.A literature search was conducted using the keywords Nano drug delivery or Nanomedical materials or Nano. A literature search was conducted in three major databases, PubMed, Web of Science, and Google Scholar, using the keywords such as Nano drug delivery, Nanomedical materials, or Nanobubble drug delivery. The initial search was screened by title and abstract. In the full-text review, the titles or abstracts were reviewed according to the selection criteria based on the inclusion criteria. The risk of bias and study quality was assessed according to the Cochrane guidelines, and possible biases such as selection bias and good selection bias were included in the review.A total of 297 studies were included in this study, of which 219 were excluded based on the screening criteria, resulting in the inclusion of 78 studies, the majority of which were original studies and clinical trials, and a small number of which provided design and route of administration analysis of nanomaterial particles and effect fluorograms and were studied in more depth. This paper summarises and reviews the views and directions of the included articles. The main directions include cyclodextrin-based or grafted cyclodextrin nanomaterials, nanobubbles, and stimuli-sensitive and temperature-sensitive nanodelivery systems.The use of innovative, targeted drug delivery systems is effective in cancer drug delivery by summarising the previous studies. However, nanodelivery systems' risks and therapeutic effects need to be evaluated before clinical application. Future research in the field of targeted drug delivery nanosystems should focus on the development of nanocarriers with high in vivo delivery capacity, good synergy with therapeutic agents, and milder short-term and long-term toxicological effects and conduct comprehensive preclinical trials on nanodrug delivery systems with high potential for clinical application as soon as possible, to find nanodrug delivery systems suitable for clinical use and put them into the clinical application as soon as possible." @default.
• W4288902561 created "2022-07-31" @default.
• W4288902561 creator A5009102557 @default.
• W4288902561 creator A5010432444 @default.
• W4288902561 creator A5016720110 @default.
• W4288902561 creator A5034219497 @default.
• W4288902561 creator A5042349998 @default.
• W4288902561 creator A5071856249 @default.
• W4288902561 creator A5080160165 @default.
• W4288902561 creator A5084094908 @default.
• W4288902561 creator A5086686723 @default.
• W4288902561 date "2022-07-30" @default.
• W4288902561 modified "2023-10-01" @default.
• W4288902561 title "Big Data Analysis of Manufacturing and Preclinical Studies of Nanodrug-Targeted Delivery Systems: A Literature Review" @default.
• W4288902561 cites W1611409620 @default.
• W4288902561 cites W1969083860 @default.
• W4288902561 cites W2059938106 @default.
• W4288902561 cites W2060887828 @default.
• W4288902561 cites W2066336297 @default.
• W4288902561 cites W2112981618 @default.
• W4288902561 cites W2113733373 @default.
• W4288902561 cites W2132789515 @default.
• W4288902561 cites W2148880307 @default.
• W4288902561 cites W2154836628 @default.
• W4288902561 cites W2168269378 @default.
• W4288902561 cites W2253117736 @default.
• W4288902561 cites W2291481902 @default.
• W4288902561 cites W2324400268 @default.
• W4288902561 cites W2339226501 @default.
• W4288902561 cites W2408703666 @default.
• W4288902561 cites W2410905501 @default.
• W4288902561 cites W2490706725 @default.
• W4288902561 cites W2544389787 @default.
• W4288902561 cites W2605906871 @default.
• W4288902561 cites W2622970549 @default.
• W4288902561 cites W2734128364 @default.
• W4288902561 cites W2772878912 @default.
• W4288902561 cites W2789181084 @default.
• W4288902561 cites W2889179116 @default.
• W4288902561 cites W2895911510 @default.
• W4288902561 cites W2896971073 @default.
• W4288902561 cites W2898106715 @default.
• W4288902561 cites W2907635071 @default.
• W4288902561 cites W2978682198 @default.
• W4288902561 cites W3009092274 @default.
• W4288902561 cites W3020168806 @default.
• W4288902561 cites W3025926158 @default.
• W4288902561 cites W3042662628 @default.
• W4288902561 cites W3043039016 @default.
• W4288902561 cites W3082773657 @default.
• W4288902561 cites W3109341071 @default.
• W4288902561 cites W3126695924 @default.
• W4288902561 cites W3133913503 @default.
• W4288902561 cites W3140145977 @default.
• W4288902561 cites W3167384022 @default.
• W4288902561 cites W3181148912 @default.
• W4288902561 cites W3203381395 @default.
• W4288902561 cites W4206584413 @default.
• W4288902561 doi "https://doi.org/10.1155/2022/1231446" @default.
• W4288902561 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35941977" @default.
• W4288902561 hasPublicationYear "2022" @default.
• W4288902561 type Work @default.
• W4288902561 citedByCount "4" @default.
• W4288902561 countsByYear W42889025612022 @default.
• W4288902561 countsByYear W42889025612023 @default.
• W4288902561 crossrefType "journal-article" @default.
• W4288902561 hasAuthorship W4288902561A5009102557 @default.
• W4288902561 hasAuthorship W4288902561A5010432444 @default.
• W4288902561 hasAuthorship W4288902561A5016720110 @default.
• W4288902561 hasAuthorship W4288902561A5034219497 @default.
• W4288902561 hasAuthorship W4288902561A5042349998 @default.
• W4288902561 hasAuthorship W4288902561A5071856249 @default.
• W4288902561 hasAuthorship W4288902561A5080160165 @default.
• W4288902561 hasAuthorship W4288902561A5084094908 @default.
• W4288902561 hasAuthorship W4288902561A5086686723 @default.
• W4288902561 hasBestOaLocation W42889025611 @default.
• W4288902561 hasConcept C112930515 @default.
• W4288902561 hasConcept C142724271 @default.
• W4288902561 hasConcept C15083742 @default.
• W4288902561 hasConcept C155672457 @default.
• W4288902561 hasConcept C171250308 @default.
• W4288902561 hasConcept C18150654 @default.
• W4288902561 hasConcept C192562407 @default.
• W4288902561 hasConcept C19527891 @default.
• W4288902561 hasConcept C2779820397 @default.
• W4288902561 hasConcept C41008148 @default.
• W4288902561 hasConcept C535046627 @default.
• W4288902561 hasConcept C71924100 @default.
• W4288902561 hasConceptScore W4288902561C112930515 @default.
• W4288902561 hasConceptScore W4288902561C142724271 @default.
• W4288902561 hasConceptScore W4288902561C15083742 @default.
• W4288902561 hasConceptScore W4288902561C155672457 @default.
• W4288902561 hasConceptScore W4288902561C171250308 @default.
• W4288902561 hasConceptScore W4288902561C18150654 @default.
• W4288902561 hasConceptScore W4288902561C192562407 @default.
• W4288902561 hasConceptScore W4288902561C19527891 @default.
• W4288902561 hasConceptScore W4288902561C2779820397 @default.
• W4288902561 hasConceptScore W4288902561C41008148 @default.

• next